eFFECTOR Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
eFFECTOR Therapeutics, Inc.
CIK #0001828522, 0001577561
EDGAR Form CIK 2011 - 2024
D [0001577561]
10-K [0001828522]
10-Q [0001828522]
3 [0001828522]
4 [0001828522]
8-K [0001828522]
SC 13D [0001828522]
SC 13G [0001828522]
Form 13D/13G Filer Form 13D/13G Subject Filed
Altitude Life Science Ventures Fund II LP Effector Therapeutics Inc [2023-03-07]
SR One Capital Management LLC Effector Therapeutics Inc [2022-02-14]
Pfizer Inc Effector Therapeutics Inc [2022-02-14]
Sectoral Asset Management Inc Effector Therapeutics Inc [2022-02-11]
US Venture Partners X LP Effector Therapeutics Inc [2021-09-13]
Column Group II LP Effector Therapeutics Inc [2021-09-07]
Abingworth LLP Effector Therapeutics Inc [2021-09-03]
Beryl Capital Management LLC Locust WALK Acquisition Corp [2021-08-20]
FEIS Lawrence Michael Locust WALK Acquisition Corp [2021-08-17]
Linden Capital LP Locust WALK Acquisition Corp [2021-02-08]
View All
Form 3/4/5 Subject 2011 - 2024
eFFECTOR Therapeutics, Inc.
Klencke Barbara
Bhatt Elizabeth
Gallagher Brian M. Jr.
Harrington-Smith Kristen
Ehrlich Christopher B
Loewy Caroline M
Worland Stephen T
Byrnes Michael
Warner Douglas J
View All
Terms | Privacy | Guide
tony@aum13f.com